Two New Executives Join VaxInnate Corporation Management Team
CRANBURY, N.J.--(BUSINESS WIRE)--VaxInnate Corporation today announced the expansion of its executive management team with the addition of Christine Mayer as Vice President of Business Development and Katalin Abraham as Vice President of Regulatory Affairs. VaxInnate is a biotechnology firm pioneering breakthrough technology for the development of novel vaccines.